Compare HLMN & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HLMN | VCEL |
|---|---|---|
| Founded | 1964 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | 2020 | 1996 |
| Metric | HLMN | VCEL |
|---|---|---|
| Price | $8.82 | $35.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $11.60 | ★ $57.75 |
| AVG Volume (30 Days) | ★ 1.0M | 557.8K |
| Earning Date | 04-27-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 122.22 | 60.00 |
| EPS | 0.20 | ★ 0.32 |
| Revenue | ★ $1,552,224,000.00 | $276,259,000.00 |
| Revenue This Year | $7.65 | $19.40 |
| Revenue Next Year | $4.67 | $18.24 |
| P/E Ratio | ★ $44.48 | $106.89 |
| Revenue Growth | 5.41 | ★ 16.45 |
| 52 Week Low | $6.63 | $28.95 |
| 52 Week High | $10.85 | $45.97 |
| Indicator | HLMN | VCEL |
|---|---|---|
| Relative Strength Index (RSI) | 55.20 | 57.65 |
| Support Level | $8.48 | $34.26 |
| Resistance Level | $9.43 | $38.48 |
| Average True Range (ATR) | 0.30 | 1.31 |
| MACD | 0.06 | 0.18 |
| Stochastic Oscillator | 75.19 | 94.02 |
Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the company are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the U.S, Canada and Mexico.
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.